Tag: FR0010451203

Rexel : Statement relating to the total number of shares and voting rights as of June 30, 2025

Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiers

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsFR0010451203

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

NTT DOCOMO BUSINESS and IIJ Unveil Integrated OT Security Management Solution for Cyber-Physical Systems

ZenaTech lista para beneficiarse de la histórica inversión de 33 mil millones de dólares en defensa de Estados Unidos para inversiones en drones y...

Tag: FR0010451203

Rexel : Statement relating to the total number of shares and voting rights as of June 30, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us